End-stage kidney disease
Disease3 papers
- Humans2
Latest
3Clinical Journal of the American Society of NephrologyHumans
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
In older veterans, primary kidney and survival risks matched with a hazard ratio of 1.00, though SGLT2 inhibitors showed lower sustained kidney…In older veterans, primary kidney and survival risks matched with a hazard ratio of 1.00, though SGLT2 inhibitors showed lower sustained kidney decline and end-stage disease.
Canadian Agency for Drugs and Technologies in Health, OttawaReview